AVITA Medical, Inc. (RCEL)
15.92
+0.74
(+4.87%)
USD |
NASDAQ |
Oct 27, 14:38
AVITA Medical Total Return Level : 15.18 for Oct. 26, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 26, 2026 | 15.18 |
| October 23, 2026 | 15.51 |
| October 22, 2026 | 15.42 |
| October 21, 2026 | 15.29 |
| October 20, 2026 | 13.80 |
| October 19, 2026 | 13.14 |
| October 16, 2026 | 13.04 |
| October 15, 2026 | 13.41 |
| October 14, 2026 | 13.10 |
| October 13, 2026 | 13.36 |
| October 12, 2026 | 13.37 |
| October 09, 2026 | 13.21 |
| October 08, 2026 | 13.33 |
| October 07, 2026 | 13.05 |
| October 06, 2026 | 12.99 |
| October 05, 2026 | 13.25 |
| October 02, 2026 | 12.72 |
| October 01, 2026 | 12.01 |
| September 30, 2026 | 11.73 |
| September 29, 2026 | 11.96 |
| September 28, 2026 | 11.67 |
| September 25, 2026 | 11.84 |
| September 24, 2026 | 11.58 |
| September 23, 2026 | 10.95 |
| September 22, 2026 | 11.49 |
| Date | Value |
|---|---|
| September 21, 2026 | 10.84 |
| September 18, 2026 | 11.02 |
| September 17, 2026 | 11.22 |
| September 16, 2026 | 10.45 |
| September 15, 2026 | 10.21 |
| September 14, 2026 | 10.19 |
| September 11, 2026 | 9.88 |
| September 10, 2026 | 9.86 |
| September 09, 2026 | 10.16 |
| September 08, 2026 | 10.41 |
| September 04, 2026 | 11.20 |
| September 03, 2026 | 10.94 |
| September 02, 2026 | 10.76 |
| September 01, 2026 | 10.07 |
| August 31, 2026 | 10.10 |
| August 28, 2026 | 10.35 |
| August 27, 2026 | 10.32 |
| August 26, 2026 | 10.59 |
| August 25, 2026 | 10.50 |
| August 24, 2026 | 9.91 |
| August 21, 2026 | 10.06 |
| August 20, 2026 | 10.09 |
| August 19, 2026 | 10.34 |
| August 18, 2026 | 9.85 |
| August 17, 2026 | 7.90 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Iovance Biotherapeutics, Inc. | 13.78 |
| Halozyme Therapeutics, Inc. | 128.01 |
| Agenus, Inc. | 6.16 |
| Amgen, Inc. | 665.80 |
| Editas Medicine, Inc. | 2.40 |